## **Core Concept**
Atrial Natriuretic Peptide (ANP) receptors are a class of receptors that play a crucial role in regulating blood pressure and electrolyte balance. ANP is a hormone released by the heart in response to increased stretch or pressure in the atria. It acts on various tissues to promote natriuresis, diuresis, and vasodilation.

## **Why the Correct Answer is Right**
The correct answer, **C. Guanylyl cyclase-linked receptors**, is right because ANP receptors are indeed linked to guanylyl cyclase, an enzyme that catalyzes the formation of cyclic guanosine monophosphate (cGMP) from guanosine triphosphate (GTP). Binding of ANP to its receptor activates guanylyl cyclase, leading to an increase in intracellular cGMP levels, which in turn mediates the biological effects of ANP, including vasodilation and natriuresis.

## **Why Each Wrong Option is Incorrect**
- **Option A:** *Enzyme-linked receptors* is a broad category that includes many types of receptors, but it is not specific enough. While ANP receptors do have enzymatic activity, specifying *guanylyl cyclase-linked receptors* is more accurate.
- **Option B:** *G protein-coupled receptors* are a large family of receptors that activate G proteins upon ligand binding, leading to various downstream effects. However, ANP receptors primarily signal through the activation of guanylyl cyclase rather than G proteins.
- **Option D:** *Ion channels* are receptors that directly open ion channels upon ligand binding, allowing ions to flow through the cell membrane. ANP receptors do not primarily function through this mechanism.

## **Clinical Pearl / High-Yield Fact**
A key point to remember is that ANP and its related peptides (e.g., brain natriuretic peptide, BNP) are crucial for diagnosing and managing heart failure. Elevated levels of BNP or NT-proBNP are used clinically to diagnose heart failure and monitor its severity. The action of ANP on promoting natriuresis and vasodilation is therapeutic in the context of heart failure.

## **Correct Answer:** C. Guanylyl cyclase-linked receptors